not logged in Login

European Urology

Supplements

Volume 11
Volume 10
Volume 9
Volume 8
Volume 7
Volume 6
Volume 5
Volume 4
Volume 3
Volume 2
Volume 1
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 6
- Issue 5
- Issue 4
- Issue 3
- Issue 2
- Issue 1

European Urology Supplements

Volume 1, issue 3, pages EX1-EX2, May 2002

Viewing articles 1-7 of 7

Apomorphine SL: Evolution of a Centrally Acting Treatment for Erectile Dysfunction

Francois Giuliano

pages 1 - 3

Abstract Full Text Full-Text PDF (62 KB)

Create Platinum Slide Series

The Role of Apomorphine SL in the Treatment of Erectile Dysfunction

Francesco Montorsi

pages 4 - 11

Abstract Full Text Full-Text PDF (145 KB)

Create Platinum Slide Series

Cross-Study Review of the Clinical Efficacy of Apomorphine SL 2 and 3 mg:: Pooled Data from Three Placebo-Controlled, Fixed-Dose Crossover Studies

C. Stief, R.J. Padley, R.J. Perdok and D.J. Sleep

pages 12 - 20

Abstract Full Text Full-Text PDF (140 KB)

Create Platinum Slide Series

Adverse Events and Patient Tolerability of Apomorphine SL 2 and 3 mg: A Cross-Study Analysis of Phase II and III Studies

D.J. Ralph, D.J. Sleep, R.J. Perdok and R.J. Padley

pages 21 - 27

Abstract Full Text Full-Text PDF (108 KB)

Create Platinum Slide Series

Safety and Tolerability of Apomorphine SL in Men with Cardiovascular Disorders

M.A. Adams, R.J. Perdok, R.J. Padley and D.J. Sleep

pages 28 - 32

Abstract Full Text Full-Text PDF (69 KB)

Patient Choice is Critical in Managing Erectile Dysfunction

J.P.W. Heaton, G. Hackett, D. Savage and R.J. Padley

pages 33 - 37

Abstract Full Text Full-Text PDF (74 KB)

Subject Index

page 38

Full-Text PDF (21 KB)

Viewing articles 1-7 of 7

Search

Listing options

More about Update Series

European Urology

Supplements

European Urology Supplements

Apomorphine SL: Evolution of a Centrally Acting Treatment for Erectile Dysfunction

The Role of Apomorphine SL in the Treatment of Erectile Dysfunction

Cross-Study Review of the Clinical Efficacy of Apomorphine SL 2 and 3 mg:: Pooled Data from Three Placebo-Controlled, Fixed-Dose Crossover Studies

Adverse Events and Patient Tolerability of Apomorphine SL 2 and 3 mg: A Cross-Study Analysis of Phase II and III Studies

Safety and Tolerability of Apomorphine SL in Men with Cardiovascular Disorders

Patient Choice is Critical in Managing Erectile Dysfunction

Subject Index

Search

Listing options

Instructions for authors

Top 10 cited